2.75
price down icon4.18%   -0.12
after-market Dopo l'orario di chiusura: 2.81 0.06 +2.18%
loading

Cardiff Oncology Inc Azioni (CRDF) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
31.41%
0.205
0.156 0.141 0.108 0.083
Operating Expenses
6.20%
11.14
10.49 10.96 12.32 12.13
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
6.20%
11.14
10.49 10.96 12.32 12.13
Operating Income/Loss
5.82%
-10.93
-10.33 -10.82 -12.21 -12.05
Nonoperating Income/Loss
7.34%
0.922
0.995 1.089 1.058 0.829
Income/Loss From Continuing Operations Before Tax
31.41%
0.205
0.156 0.141 -11.15 -11.22
Income/Loss From Continuing Operations After Tax
7.22%
-10.01
-9.337 -9.731 -11.15 -11.22
Net Income/Loss
7.22%
-10.01
-9.337 -9.731 -11.15 -11.22
Preferred Stock Dividends And Other Adjustments
0.00%
0.006
0.006 0.006 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
44.68
- 44.68 44.68 44.68
Diluted Average Shares
44.68
- 44.68 44.68 44.68
Basic Earnings Per Share
4.76%
-0.22
-0.21 -0.22 -0.25 -0.25
Diluted Earnings Per Share
4.76%
-0.22
-0.21 -0.22 -0.25 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.00%
0.006
0.006 0.006 - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):